Sandoz Group (OTCMKTS:SDZNY) Reaches New 12-Month High – Here’s Why

Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY)’s stock price reached a new 52-week high during trading on Wednesday. The company traded as high as $95.00 and last traded at $94.50, with a volume of 3,631 shares trading hands. The stock had previously closed at $93.56.

Analysts Set New Price Targets

Separately, Erste Group Bank raised shares of Sandoz Group to a “strong-buy” rating in a research note on Thursday, August 27th. Four investment analysts have rated the stock with a Strong Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Strong Buy”.

Sandoz Group Trading Up 1.6%

The stock has a fifty day moving average of $86.45 and a two-hundred day moving average of $84.56.

Sandoz Group Company Profile

Sandoz Group AG is a Switzerland-based pharmaceutical company focused on generic and biosimilar medicines. Its portfolio includes prescription medicines across therapeutic areas such as anti-infectives, immunology, oncology, ophthalmology, respiratory care and cardiovascular treatments. The company also supplies complex generics, including injectable, inhaled and other specialty formulations.

Sandoz serves patients and healthcare providers through a broad international commercial and manufacturing network, with operations and products spanning Europe, North America, Asia and other global markets.